Related Experiment Video
Updated: Aug 29, 2025
14:39
Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
Published on: November 4, 2010
32.0K
Ferroptosis, novel therapeutics in asthma
Xiaodi Lv1, Ming Dong2, Weifeng Tang1
1Department of Integrative Medicine, Huashan Hospital, Fudan University, Shanghai, China; Institutes of Integrative Medicine, Fudan University, Shanghai, China.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|September 9, 2022
Summary
Ferroptosis, an iron-dependent cell death, is linked to immune responses and asthma. Understanding this connection offers new therapeutic targets for asthma management.
Area of Science:
- Immunology
- Cell Biology
- Pathology
Background:
- Ferroptosis, a regulated cell death form, is increasingly linked to immune system functions.
- Existing research highlights ferroptosis's role in cancer, ischemia, and degenerative diseases.
- The specific relationship between ferroptosis and asthma pathogenesis remains underexplored.
Purpose of the Study:
- To elucidate the molecular mechanisms linking ferroptosis and asthma.
- To explore common regulatory cells and molecules between ferroptosis and asthma.
- To discuss ferroptosis as a potential therapeutic strategy for asthma.
Main Methods:
- Review of current literature on ferroptosis and asthma.
- Analysis of molecular pathways involved in both processes.
- Identification of shared regulatory elements.
Main Results:
- Ferroptosis and asthma share common regulatory cells and molecules, particularly within immune system components.
- Ferroptosis signaling pathways are implicated in asthma inflammation.
- Non-immune cells involved in asthma also exhibit ferroptosis-related characteristics.
Conclusions:
- Ferroptosis offers a novel framework for understanding asthma pathogenesis.
- Targeting ferroptosis regulators presents potential therapeutic avenues for asthma.
- Further research into ferroptosis in asthma could improve treatment outcomes and patient prognosis.
Related Concept Videos
01:20Asthma: Pathogenesis and Management
541
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
541
01:26COPD: Management Using Bronchodilators and Corticosteroids
283
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
283
01:26Asthma-II: Pathophysiology and Classification
2.8K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.8K
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
413
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
413
01:30Asthma-IV: Diagnostic and Management
2.6K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.6K
01:20COPD: Pathogenesis and Clinical Features
468
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
468